We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
290 result(s) found, displaying 61 to 70
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHADONE-AFT methadone hydrochloride 5 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARSENIC TRIOXIDE-AFT arsenic trioxide 12 mg/12 mL concentrated solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHADONE-AFT methadone hydrochloride 10 mg tablet blister pack.
-
Prescription medicine registrationActive ingredients: daptomycin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ferro-MR + Vit C modified release tablets.
-
Prescription medicine registrationActive ingredients: cyclizine lactate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Ibuprofen Soft Gel Caps.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Vitamin D3 Weekly Soft Capsule, Colecalciferol 175 Micrograms (7000 IU), Blister Pack.
-
HYOSCINE BUTYLBROMIDE - AFT hyoscine butylbromide 20 mg/1 mL solution for injection ampoule (369870)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HYOSCINE BUTYLBROMIDE - AFT hyoscine butylbromide 20 mg/1 mL solution for injection ampoule.